Scientists are looking toward microglia cells as therapeutic targets for Alzheimer’s. Microglia, known as the janitors of our brains, are responsible for clearing harmful…
Using the blue device (pictured) that performs the ultrasensitive proximity extension assay technology, Professor Nancy Ip Yuk-Yu and her team have developed a blood…
Researchers share insights on the infectious theory of Alzheimer’s—the idea viruses and bacteria may cause Alzheimer’s. Clinical trials are underway to test this theory….
Nikki Schultek, founder of the global medical research consortium Intracell Research Group, takes a close look at how the COVID-19 pandemic may prompt a…
Bad news arrived recently for the constantly caffeinated: Researchers recently found evidence that drinking more than six cups of coffee a day could shrink…
IMAGE: Photobiomodulation tabletop device Beacon40 by neurotechnology company Bright Could flickering lights have brain health benefits? Research around experimental therapies involving external stimuli —…
A recent cell study shows that experimental Parkinson’s and Alzheimer’s antibodies may trigger harmful brain inflammation—which could explain clinical trials’ dismal failure rates. In…
A recent analysis reveals that people with Alzheimer’s taking Alzheimer’s drug galantamine (Razadyne), approved nearly two decades ago, show moderate cognitive benefits as well…
Scientists in the field of Alzheimer’s have struggled to carry promising findings in mice studies into human trials, but primate researchers believe that animals…
From the nature of Alzheimer’s to the solutions available for controlling it, here are five common misconceptions to dispel. Alzheimer’s is the sixth leading…
Scientists still don’t know why some people develop Alzheimer’s and others don’t. But while we may not fully understand the causes of Alzheimer’s, researchers…
Cassava Sciences revealed positive clinical data from their simufilam trial, a potentially disease-modifying therapy for treating Alzheimer’s. Their preliminary study showed that simufilam significantly…
New research suggests that reducing harmful air pollutants can decrease dementia risk by up to 26 percent. Exposure to air pollution is widely known…
Research has shown that glucose levels, the brain’s primary source of fuel, in the central nervous system diminishes in aging, and some researchers suggest that…
UPDATE: 3 March 2024, 8:22 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…